MYRIAD GENETICS INC Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MYRIAD GENETICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in MYRIAD GENETICS INC for February 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2014 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Option Exercise | M | 24.40 | 30,000 | 732,000 | 0 | |
| Feb 26 2014 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Sell | S | 37.58 | 30,000 | 1,127,319 | 0 | 30 K to 0 (-100.00 %) |
| Feb 26 2014 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Buy | M | 24.40 | 30,000 | 732,000 | 30,000 | 0 to 30 K |
| Feb 25 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 19.47 | 64,000 | 1,246,080 | 144,000 | |
| Feb 25 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 18.00 | 31,250 | 562,500 | 25,695 | |
| Feb 25 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 37.83 | 31,250 | 1,182,188 | 48,268 | 79.5 K to 48.3 K (-39.30 %) |
| Feb 25 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 18.00 | 31,250 | 562,500 | 79,518 | 48.3 K to 79.5 K (+64.74 %) |
| Feb 25 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 37.83 | 64,000 | 2,421,120 | 48,268 | 112.3 K to 48.3 K (-57.01 %) |
| Feb 25 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 19.47 | 64,000 | 1,246,080 | 112,268 | 48.3 K to 112.3 K (+132.59 %) |
| Feb 24 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 18.00 | 20,000 | 360,000 | 34,445 | |
| Feb 24 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 38.00 | 20,000 | 760,000 | 2,949 | 22.9 K to 2.9 K (-87.15 %) |
| Feb 24 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 18.00 | 20,000 | 360,000 | 22,949 | 2.9 K to 22.9 K (+678.20 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 14.88 | 25,000 | 372,000 | 48,120 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 34.74 | 25,000 | 868,550 | 2,949 | 27.9 K to 2.9 K (-89.45 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 14.88 | 25,000 | 372,000 | 27,949 | 2.9 K to 27.9 K (+847.74 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Option Exercise | M | 12.17 | 5,236 | 63,722 | 0 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Option Exercise | M | 18.06 | 2,230 | 40,274 | 0 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Option Exercise | M | 13.28 | 5,324 | 70,703 | 0 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Option Exercise | M | 12.17 | 4,764 | 57,978 | 0 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Sell | S | 36.22 | 5,236 | 189,632 | 324 | 5.6 K to 324 (-94.17 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Buy | M | 12.17 | 5,236 | 63,722 | 5,560 | 324 to 5.6 K (+1,616.05 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Sell | S | 36.22 | 4,764 | 172,538 | 324 | 5.1 K to 324 (-93.63 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Buy | M | 12.17 | 4,764 | 57,978 | 5,088 | 324 to 5.1 K (+1,470.37 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Sell | S | 36.22 | 2,230 | 80,764 | 324 | 2.6 K to 324 (-87.31 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Buy | M | 18.06 | 2,230 | 40,274 | 2,554 | 324 to 2.6 K (+688.27 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Sell | S | 36.22 | 5,324 | 192,819 | 324 | 5.6 K to 324 (-94.26 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Buy | M | 13.28 | 5,324 | 70,703 | 5,648 | 324 to 5.6 K (+1,643.21 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | DREISMANN HEINRICH | Director | Option Exercise | M | 21.29 | 30,000 | 638,700 | 0 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | DREISMANN HEINRICH | Director | Sell | S | 35.00 | 30,000 | 1,050,000 | 0 | 30 K to 0 (-100.00 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | DREISMANN HEINRICH | Director | Buy | M | 21.29 | 30,000 | 638,700 | 30,000 | 0 to 30 K |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 7.27 | 30,000 | 218,100 | 0 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 36.01 | 30,000 | 1,080,375 | 47,609 | 77.6 K to 47.6 K (-38.66 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 7.27 | 30,000 | 218,100 | 77,609 | 47.6 K to 77.6 K (+63.01 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Option Exercise | M | 21.66 | 30,000 | 649,800 | 0 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Option Exercise | M | 21.29 | 30,000 | 638,700 | 0 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Sell | S | 34.48 | 30,000 | 1,034,310 | 0 | 30 K to 0 (-100.00 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Buy | M | 21.66 | 30,000 | 649,800 | 30,000 | 0 to 30 K |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Sell | S | 34.48 | 30,000 | 1,034,310 | 0 | 30 K to 0 (-100.00 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Buy | M | 21.29 | 30,000 | 638,700 | 30,000 | 0 to 30 K |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 13.28 | 10,000 | 132,800 | 54,676 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 12.17 | 24,192 | 294,417 | 0 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 34.55 | 24,192 | 835,754 | 17,551 | 41.7 K to 17.6 K (-57.95 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 12.17 | 24,192 | 294,417 | 41,743 | 17.6 K to 41.7 K (+137.84 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 34.55 | 10,000 | 345,467 | 17,551 | 27.6 K to 17.6 K (-36.30 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 13.28 | 10,000 | 132,800 | 27,551 | 17.6 K to 27.6 K (+56.98 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 13.28 | 34,676 | 460,497 | 30,000 | |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | S | 34.71 | 34,676 | 1,203,736 | 17,165 | 51.8 K to 17.2 K (-66.89 %) |
| Feb 20 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 13.28 | 34,676 | 460,497 | 51,841 | 17.2 K to 51.8 K (+202.02 %) |
| Feb 14 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 7.82 | 20,960 | 163,907 | 0 | |
| Feb 14 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | S | 31.50 | 20,960 | 660,223 | 17,165 | 38.1 K to 17.2 K (-54.98 %) |
| Feb 14 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 7.82 | 20,960 | 163,907 | 38,125 | 17.2 K to 38.1 K (+122.11 %) |
| Feb 14 2014 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Gift | G | 0.00 | 4,196 | 0 | 17,165 | 21.4 K to 17.2 K (-19.64 %) |
| Feb 12 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Option Exercise | M | 7.82 | 2,500 | 19,550 | 0 | |
| Feb 12 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Option Exercise | M | 7.82 | 7,500 | 58,650 | 2,500 | |
| Feb 12 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Option Exercise | M | 6.00 | 506 | 3,036 | 0 | |
| Feb 12 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Sell | S | 30.72 | 3,201 | 98,344 | 324 | 3.5 K to 324 (-90.81 %) |
| Feb 12 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Sell | S | 30.74 | 506 | 15,557 | 3,525 | 4 K to 3.5 K (-12.55 %) |
| Feb 12 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Buy | M | 6.00 | 506 | 3,036 | 4,031 | 3.5 K to 4 K (+14.35 %) |
| Feb 12 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Sell | S | 30.74 | 2,500 | 76,861 | 3,525 | 6 K to 3.5 K (-41.49 %) |
| Feb 12 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Buy | M | 7.82 | 2,500 | 19,550 | 6,025 | 3.5 K to 6 K (+70.92 %) |
| Feb 12 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Sell | S | 30.74 | 7,500 | 230,583 | 3,525 | 11 K to 3.5 K (-68.03 %) |
| Feb 12 2014 | MYGN | MYRIAD GENETICS IN ... | Harrison Robert Gardner | Chief Information O ... | Buy | M | 7.82 | 7,500 | 58,650 | 11,025 | 3.5 K to 11 K (+212.77 %) |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 7.82 | 26,250 | 205,275 | 0 | |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 7.82 | 8,750 | 68,425 | 26,250 | |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 33.04 | 26,250 | 867,363 | 47,609 | 73.9 K to 47.6 K (-35.54 %) |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 7.82 | 26,250 | 205,275 | 73,859 | 47.6 K to 73.9 K (+55.14 %) |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 33.04 | 8,750 | 289,121 | 47,609 | 56.4 K to 47.6 K (-15.53 %) |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 7.82 | 8,750 | 68,425 | 56,359 | 47.6 K to 56.4 K (+18.38 %) |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 18.00 | 62,500 | 1,125,000 | 56,945 | |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 16.53 | 25,000 | 413,250 | 25,000 | |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 32.07 | 62,500 | 2,004,225 | 48,268 | 110.8 K to 48.3 K (-56.42 %) |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 18.00 | 62,500 | 1,125,000 | 110,768 | 48.3 K to 110.8 K (+129.49 %) |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 32.07 | 25,000 | 801,690 | 48,268 | 73.3 K to 48.3 K (-34.12 %) |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 16.53 | 25,000 | 413,250 | 73,268 | 48.3 K to 73.3 K (+51.79 %) |
| Feb 05 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 8.63 | 31,804 | 274,469 | 0 | |
| Feb 05 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 8.63 | 32,000 | 276,160 | 31,804 | |
| Feb 05 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 7.82 | 9,040 | 70,693 | 0 | |
| Feb 05 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 7.27 | 51,096 | 371,468 | 0 | |
| Feb 05 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Sell | S | 30.78 | 9,040 | 278,289 | 55,656 | 64.7 K to 55.7 K (-13.97 %) |
| Feb 05 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Buy | M | 7.82 | 9,040 | 70,693 | 64,696 | 55.7 K to 64.7 K (+16.24 %) |
| Feb 05 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Sell | S | 30.78 | 51,096 | 1,572,949 | 55,656 | 106.8 K to 55.7 K (-47.86 %) |
| Feb 05 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Buy | M | 7.27 | 51,096 | 371,468 | 106,752 | 55.7 K to 106.8 K (+91.81 %) |
| Feb 05 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Sell | S | 30.78 | 31,804 | 979,061 | 55,656 | 87.5 K to 55.7 K (-36.36 %) |
| Feb 05 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Buy | M | 8.63 | 31,804 | 274,469 | 87,460 | 55.7 K to 87.5 K (+57.14 %) |
| Feb 05 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Sell | S | 32.00 | 32,000 | 1,024,000 | 55,656 | 87.7 K to 55.7 K (-36.51 %) |
| Feb 05 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Buy | M | 8.63 | 32,000 | 276,160 | 87,656 | 55.7 K to 87.7 K (+57.50 %) |